Search results for "INDEX"

showing 10 items of 5395 documents

Clinical course of rhinitis and changes in vivo and in vitro of allergic parameters in elderly patients: a long-term follow-up study

2012

Changes in rhinitis symptom severity tend to decrease with aging, but whether the decrease is associated with allergic skin test reactivity, serum total and specific IgE, and nasal eosinophils or determined only by aging is poorly understood. The aim of the study was to analyze sensitivity in vivo and in vitro some 15 years after primary testing, skin prick test (SPT), serum total and specific IgE, ratio sIgE/tIgE, and nasal eosinophils in order to evaluate changes due to age and changes due to the severity of rhinitis symptoms. One hundred and eight rhinitis patients who had been investigated in 1995 were re-interviewed and their current allergy re-assessed after a follow-up of 15 years. A…

AdultMaleAgingmedicine.medical_specialtyAllergySettore MED/09 - Medicina InternaRhinitis Allergic PerennialMucous membrane of noseImmunoglobulin ESeverity of Illness IndexGeneral Biochemistry Genetics and Molecular BiologySerum total IgEIn vivoInternal medicineSeverity of illnessAllergic rhinitimedicineHumansAgedSkinHematologybiologybusiness.industrySerum-specific IgEAge FactorsClinical courseGeneral MedicineImmunoglobulin EMiddle Agedmedicine.diseaseRhinitis AllergicSymptom scoreIn vitroEosinophil in nasal fluidEosinophilsNasal MucosaItalyImmunologybiology.proteinFemalebusinessFollow-Up StudiesClinical and Experimental Medicine
researchProduct

Basal concentrations and acute responses of serum hormones andstrength development during heavy resistance training in middle-aged andelderly men and…

2000

Effects of 6 months of heavy resistance training combined with explosive exercises on both basal concentrations and acute responses of total and free testosterone, growth hormone (GH), dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEAS), cortisol and sex hormone-binding globulin (SHBG), as well as voluntary neural activation and maximal strength of knee extensors were examined in 10 middle-aged men (M40; 42 +/- 2 years), 11 middle-aged women (W40; 39 +/- 3 years), 11 elderly men (M70; 72 +/- 3 years), and in 10 elderly women (W70; 67 +/- 3 years). The maximal integrated electromyographic (iEMG) and 1 repetition maximum (RM) knee-extension values remained unaltered in all g…

AdultMaleAgingmedicine.medical_specialtyHydrocortisoneKnee JointWeight LiftingStrength trainingDehydroepiandrosteroneBody Mass Indexchemistry.chemical_compoundBasal (phylogenetics)Dehydroepiandrosterone sulfateSex hormone-binding globulinSex Hormone-Binding GlobulinInternal medicinemedicineHumansTestosteroneMuscle SkeletalTestosteroneAgedHydrocortisonebiologyDehydroepiandrosterone SulfateElectromyographyHuman Growth Hormonebusiness.industryAge FactorsDehydroepiandrosteroneMiddle AgedHormonesEndocrinologychemistryMultivariate AnalysisLactatesbiology.proteinFemaleGeriatrics and GerontologybusinessFollow-Up StudiesMuscle Contractionmedicine.drugHormoneThe Journals of Gerontology Series A: Biological Sciences and Medical Sciences
researchProduct

Factors associated with maximal walking speed among older community-living adults.

2011

Background and aims: The relative contribution of different domains on walking speed is largely unknown. This study investigated the central factors associated with maximal walking speed among older people. Methods: Cross-sectional analyses of baseline data from the SCAMOB study (ISRCTN 07330512) involving 605 community-living ambulatory adults aged 75–81 years. Maximal walking speed, leg extensor power, standing balance and body mass index were measured at the research center. Physical activity, smoking, use of alcohol, chronic diseases and depressive symptoms were self-reported by standard questionnaires. Results: The mean maximal walking speed was 1.4 m/s (range 0.3–2.9). In linear regre…

AdultMaleAgingmedicine.medical_specialtyPosturePhysical activityWalkingModels BiologicalBody Mass IndexPhysical medicine and rehabilitationCommunity livingLinear regressionPostural BalanceMedicineHumansGaitFinlandAgedRandomized Controlled Trials as TopicAged 80 and overbusiness.industrymedicine.diseaseObesityPreferred walking speedCross-Sectional StudiesAmbulatoryPhysical therapyFemaleHousing for the ElderlyGeriatrics and GerontologybusinessBody mass indexAging clinical and experimental research
researchProduct

Longitudinal study of alexithymia and multiple sclerosis

2013

Objective The aim of this study was to investigate the course of alexithymia and its relation with anxiety and depression in patients with multiple sclerosis (MS), over a period of 5 years. Methods Sixty-two MS patients were examined at two timepoints, 5 years apart, and they answered questionnaires collecting socio-demographic, medical, and psychological data (depression, anxiety, alexithymia). Results Our data show that emotional disorders remain stable over time in patients with MS, particularly as regards alexithymia and anxiety. Conversely, the rate of depression decreased between the two evaluations, falling from 40% to 26%. The two dimensions of alexithymia (i.e., difficulty describi…

AdultMaleAlexithymiaChange over timemedicine.medical_specialtyLongitudinal studyMultiple Sclerosismedia_common.quotation_subjectAnxietySeverity of Illness IndexYoung AdultBehavioral NeuroscienceAlexithymiamedicineHumansIn patientAffective SymptomsLongitudinal StudiesPsychiatryDepression (differential diagnoses)AgedOriginal Researchmedia_commonDepressionMultiple sclerosislongitudinal studyMiddle Agedmedicine.diseaseFeelingAnxietyFemalemedicine.symptomPsychologyClinical psychologyBrain and Behavior
researchProduct

Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis

2019

Background: The course of multiple sclerosis (MS) shows substantial inter-individual variability. The underlying determinants of disease severity likely involve genetic and environmental factors. Objective: The aim of this study was to assess the impact of APOE and HLA polymorphisms as well as smoking and body mass index (BMI) in the very early MS course. Methods: Untreated patients ( n = 263) with a recent diagnosis of relapsing-remitting (RR) MS or clinically isolated syndrome underwent standardized magnetic resonance imaging (MRI). Genotyping was performed for single-nucleotide polymorphisms (SNPs) rs3135388 tagging the HLA-DRB1*15:01 haplotype and rs7412 (Ɛ2) and rs429358 (Ɛ4) in APOE. …

AdultMaleApolipoprotein EMultiple SclerosisAdolescentPolymorphism Single NucleotideBody Mass IndexYoung Adult03 medical and health sciencesApolipoproteins E0302 clinical medicineAtrophyMedizinische FakultätmedicineHumansSNPGenetic Predisposition to Disease030212 general & internal medicineddc:610Risk factorHLA-DRB1Agedbusiness.industryMultiple sclerosisSmokingNeurodegenerationBrainMiddle Agedmedicine.diseaseNeurologyImmunologyFemaleNeurology (clinical)AtrophybusinessBody mass index030217 neurology & neurosurgeryHLA-DRB1 Chains
researchProduct

Associations of LPL and APOC3 gene polymorphisms on plasma lipids in a mediterranean population: Interaction with tobacco smoking and the APOE locus

2002

We conducted a cross-sectional study in a Spanish population (n = 1,029) to investigate associations between the LPL and APOC3 gene loci (LPL-HindIII, LPL-S447X, and APOC3-SstI) and plasma lipid levels and their interaction with APOE polymorphisms and smoking. Carriers of the H− or the X447 allele had higher levels of HDL cholesterol (HDL-C), and lower levels of TG, after adjustment for age, body mass index, alcohol, smoking, exercise, and education (P < 0.01). The APOC3 polymorphism presented additive effects to the LPL variants on TG and HDL-C levels in men, and on TG in women. The most and the least favorable haplotype combinations were H−/X447/S1 and H+/S447/S2, respectively. These comb…

AdultMaleApolipoprotein Emedicine.medical_specialtyapolipoprotein C-IIIPopulationlipoprotein lipaseLocus (genetics)Deoxyribonuclease HindIIIQD415-436Biochemistrylipidschemistry.chemical_compoundApolipoproteins EEndocrinologyInternal medicineHumansMedicineAlleleApolipoproteins CDeoxyribonucleases Type II Site-SpecificeducationTriglyceridesGeneticseducation.field_of_studyLipoprotein lipasePolymorphism Geneticbusiness.industryCholesterolCholesterol HDLSmokingHaplotypeGenetic Variationnutritional and metabolic diseasesCell BiologyCross-Sectional StudiesEndocrinologychemistrySpainFemalelipids (amino acids peptides and proteins)gene-environmental interactionbusinessBody mass index
researchProduct

Risk of surgical site infections following hip and knee arthroplasty: Results of the ischia-gisio study

2017

Surgical Site Infection (SSI) is one of the major complications following insertion of hip or knee prosthesis. The aim of the present study was to describe rates of SSIs and associated risk factors during hip and knee prosthesis procedures in Italian hospitals. METHODS: Italian hospitals were invited to join the ISChIA (Surgical Site Infections in Arthroplasty Surgery) project and participated in the study on a voluntary basis. SSI surveillance was performed according to the Hospitals in Europe Link for Infection Control through Surveillance (HELICS) -SSI protocol. The study population consisted of all patients who had a prosthetic knee or hip joint replacement between March 2010 and Februa…

AdultMaleArthroplasty Replacement HipOperative TimeSettore MED/42 - Igiene Generale E ApplicataYoung AdultRisk FactorsSettore MED/33 - Malattie Apparato LocomotoreHumansSurgical Wound InfectionProspective StudiesArthroplasty Replacement KneeAgedAged 80 and overInfection Risk Index Operation length Surgical site infection SurveillanceSurveillanceIncidenceEnvironmental and Occupational HealthInfection Risk IndexMiddle AgedOperation lengthinfection risk index; operation length; surgical site infection; surveillance; public health environmental and occupational health; infectious diseasesInfectious DiseasesItalyPopulation SurveillanceMultivariate AnalysisFemalePublic HealthSurgical site infection
researchProduct

Preference for attractiveness and thinness in a partner: Influence of internalization of the thin ideal and shape/weight dissatisfaction in heterosex…

2009

This study assesses whether characteristics of one's own body image influences preferences of attractiveness in a partner. The role of gender and sexual orientation is also considered. Heterosexual women (n=67), lesbian women (n=73), heterosexual men (n=61) and gay men (n=82) participated in an internet survey assessing attitudes towards the body and preferences of attractiveness in a partner. Men in particular were found to prefer attractive partners, regardless of sexual orientation. Weight/shape dissatisfaction was found to be a negative predictor for heterosexual men and women. For gay men, preferences were better explained by internalization and weight/shape dissatisfaction. No such as…

AdultMaleAttractivenessAdolescentSocial ValuesSocial Psychologymedia_common.quotation_subjecteducationPersonal SatisfactionSocial value orientationsChoice BehaviorBody Mass IndexBeautyYoung AdultThinnessThe Thin IdealBody ImageBody SizeHumansHomosexualityHomosexuality MaleHeterosexualityInternal-External ControlGeneral PsychologyApplied Psychologymedia_commonBody WeightHomosexuality FemaleHealth SurveysPreferenceSexual PartnersSexual orientationFemaleLesbianPsychologyBody mass indexSocial psychologyBody Image
researchProduct

A Highly Decreased Binding of Cyclic Adenosine Monophosphate to Protein Kinase A in Erythrocyte Membranes is Specific for Active Psoriasis

2002

A cyclic adenosine monophosphate binding abnormality in psoriatic erythrocytes that could be corrected by retinoid treatment has been reported. It was tested whether this binding abnormality is specific for psoriasis and the effects of treatment were compared with etretinate, cyclosporine A, or anthralin on 2-(3)H-8-N(3)-cyclic adenosine monophosphate binding to the regulatory subunit of protein kinase A in erythrocyte membranes. One hundred and fifteen individuals were evaluated, including: (i) 34 healthy persons; (ii) 15 patients with nonatopic inflammatory skin diseases (eczema, erythroderma, tinea, Grover's disease, erysipelas, urticaria); (iii) eight with other dermatoses mediated by i…

AdultMaleAzidesmedicine.medical_specialtyAdolescentmedicine.drug_classAdministration TopicalAnti-Inflammatory AgentsErythrodermaEtretinateDermatologySeverity of Illness IndexBiochemistryRetinoidschemistry.chemical_compoundPsoriasis Area and Severity IndexKeratolytic AgentsPsoriasis Area and Severity IndexPsoriasisInternal medicineCyclic AMPmedicineHumansPsoriasisCyclic adenosine monophosphateRetinoidMolecular BiologydermatitisAgedErythema nodosumbusiness.industryErythrocyte MembraneAffinity LabelsCell BiologyAtopic dermatitisAnthralinMiddle Agedmedicine.diseaseCyclic AMP-Dependent Protein KinasesEndocrinologychemistryEtretinateCyclosporineFemaleDermatologic Agentsbusinesscyclosporine AProtein Bindingmedicine.drugJournal of Investigative Dermatology
researchProduct

Body mass index as a determinant of clozapine plasma concentrations: A pharmacokinetic-based hypothesis

2021

Background: Knowledge regarding the impact of body composition measures on pharmacokinetics of antipsychotics is limited. Aims: Our aim was to investigate the impact of body weight and body mass index on clozapine pharmacokinetics using a therapeutic drug monitoring database. Methods: A large therapeutic drug monitoring dataset of clozapine plasma concentrations considering three patient subgroups was analysed: a control group (CLZ0, 20–30 kg/m2, n=266), a group with high body mass index (CLZhigh, body mass index ⩾30 kg/m2, n=162) and with low body mass index values (CLZlow, body mass index &lt;20 kg/m2, n=27). Comparisons of plasma and dose-adjusted plasma concentrations (C/D) of clozapine…

AdultMaleBiological AvailabilityPharmacologyBody weightBody Mass IndexYoung Adult03 medical and health sciencesSex Factors0302 clinical medicinePharmacokineticsmedicineHumansTissue DistributionPharmacology (medical)ObesityClozapineClozapineAgedRetrospective StudiesA determinantAged 80 and overPharmacologymedicine.diagnostic_testbusiness.industryBody WeightMiddle Agedmedicine.diseaseObesity030227 psychiatryPsychiatry and Mental healthAdipose TissueLiverTherapeutic drug monitoringPlasma concentrationFemaleDrug MonitoringbusinessBody mass index030217 neurology & neurosurgeryAntipsychotic Agentsmedicine.drugJournal of Psychopharmacology
researchProduct